Circulating Tumor DNA to Serially Assess in vivo Transcriptional Evolution in Cancers ASPIRE Award (2022-2023) Sarah-Jane Dawson, MD, PhD, Peter MacCallum Cancer Centre, The University of Melbourne (Australia) Read More
Hijacking Immune-Cell Specific E3 Ligases for Targeted Protein Degradation ASPIRE Award (2022-2023) Georg Winter, PhD, CeMM- Research Center for Molecular Medicine (Austria); Steve Gygi, PhD, Harvard Medical School Read More
Harnessing Induced Proximity to Expand Cancer Therapeutic Modalities ASPIRE Award (2022-2024) Mikko Taipale, PhD, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto; Daniel Durocher, PhD, Frank Sicheri, PhD, Mount Sinai Hospital (Canada) Read More
Defining Tumor Infiltrating B Cells and Their Role in the Modulation of TIL Immunotherapy ASPIRE Award (2022-2023) Shari Pilon-Thomas, PhD; Daniel Abate-Daga, PhD, H. Lee Moffitt Cancer Center and Research Institute; Yong-Chen Lu, PhD, University of Arkansas for Medical Sciences Read More
Reprograming Regulatory T Cells for Cancer Immunotherapy ASPIRE Award (2022-2023) Xiongbin Lu, PhD, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA Read More
Targeting SCLC Plasticity with Constellation Pharmacology ASPIRE Award (2022-2024) Trudy Oliver, PhD; Baldomero Olivera, PhD, Huntsman Cancer Institute at the University of Utah Read More
